BIOMAT Database Logo BIOMAT Database Logo

Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. 1990

T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, La Jolla, CA.

We studied IgG antibody levels to synthetic peptides (p62, E11 and E3) from Epstein-Barr nuclear antigen-1 (EBNA-1) protein sequence in sera of patients with rheumatoid arthritis (RA), in pre-RA and in rheumatoid factor (RF) positive non-RA sera from Finland. Anti-E11 and anti-E3 antibody levels were significantly elevated in RA sera, compared with both RF negative and RF positive nonrheumatoid controls. The concentrations of anti-E11 and anti-E3 antibodies in the preillness sera were lower than those in RA sera. Eight-year followup samples of patients with RA had slightly decreased levels of anti-E3 and anti-E11 antibodies compared with samples taken within 6 months of the disease onset. Anti-p62 antibody levels did not differ significantly between any of the groups studied. Thus, elevated levels of antibodies to 2 of the glycine containing EBNA-1 peptides were associated with clinical RA.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1.
April 1988, Annals of the rheumatic diseases,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis.
November 1986, The Journal of infectious diseases,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
January 1982, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
August 1986, Arthritis and rheumatism,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Rheumatoid arthritis nuclear antigen and Epstein-Barr virus.
April 1984, Arthritis and rheumatism,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide.
December 1983, Proceedings of the National Academy of Sciences of the United States of America,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
January 1985, Journal of immunology (Baltimore, Md. : 1950),
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Anti-Epstein-Barr virus-nuclear antigen-1, -2A and -2B antibodies in rheumatoid arthritis patients and their relatives.
January 1992, Autoimmunity,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.
July 1985, The EMBO journal,
T Kouri, and J Petersen, and G Rhodes, and K Aho, and T Palosuo, and M Heliövaara, and H Isomäki, and R von Essen, and J H Vaughan
Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis.
October 1984, Journal of virology,
Copied contents to your clipboard!